指南与共识前列腺癌

临床局限性前列腺癌:AUA/ASTRO/SUO 指南第二部分——推荐方法与具体治疗选择详解

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options.
指南 / 共识 · J Urol · 2018-01-10

该指南由 AUA、ASTRO 与 SUO 制定,基于 2007 年 1 月至 2014 年 3 月的系统综述及截至 2016 年 8 月的更新检索,按癌症严重程度分层提供临床框架,指导具体治疗选择的实施;强调选择管理策略时应考虑患者偏好,并指出未来需要更高质量证据。

要点

  • 指南按癌症严重程度分层构建临床框架,以辅助治疗决策并指导具体管理选项的实施。
  • 证据体按 A(高)、B(中)、C(低)分级,分别支持强、中等或有条件推荐。
  • 选择管理策略时应考虑患者偏好;未来试验的更高质量证据对改善诊疗至关重要。

核心结论

  • 该指南按癌症严重程度分层提供临床框架,以辅助治疗决策并指导具体管理选项的实施。
  • 选择管理策略时应考虑患者偏好。
  • 未来试验的更高质量证据对改善此类患者的诊疗水平至关重要。

研究设计与样本

  • 系统综述由美国医疗保健研究与质量局完成,并由 ECRI 研究所补充。
  • 检索纳入 2007 年 1 月至 2014 年 3 月发表的文献,更新检索截至 2016 年 8 月。
  • 证据充分时,对特定治疗证据体赋予 A(高)、B(中)、C(低)强度评级,分别支持强、中等或有条件推荐。

主要发现

  • AUA、ASTRO 与 SUO 基于风险分层的临床框架制定了循证指南。
  • 该指南按癌症严重程度分层讨论风险分层与治疗选择。

关键数值与推荐

  • 证据强度评级:A(高)、B(中)、C(低),分别支持强、中等或有条件推荐。
  • 补充信息以临床原则与专家意见形式提供。

临床怎么用

  • 临床医生可依据按癌症严重程度分层的框架选择与管理局限性前列腺癌。
  • 选择管理策略时应考虑患者偏好。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This guideline is structured to provide a clinical framework stratified by cancer severity to facilitate care decisions and guide the specifics of implementing the selected management options. The summary presented herein represents Part II of the two-part series dedicated to Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline discussing risk stratification and care options by cancer severity. Please refer to Part I for discussion of specific care options and outcome expectations and management. MATERIALS AND METHODS: The systematic review utilized in the creation of this guideline was completed by the Agency for Healthcare Research and Quality and through additional supplementation by ECRI Institute. This review included articles published between January 2007 and March 2014 with an update search conducted through August 2016. When sufficient evidence existed, the body of evidence for a particular treatment was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. Additional information is provided as Clinical Principles and Expert Opinions (table 2 in supplementary unabridged guideline, http://jurology.com/). RESULTS: The AUA (American Urological Association), ASTRO, and SUO (Society of Urologic Oncology) formulated an evidence-based guideline based on a risk stratified clinical framework for the management of localized prostate cancer. CONCLUSIONS: This guideline attempts to improve a clinician's ability to treat patients diagnosed with localized prostate cancer, but higher quality evidence in future trials will be essential to improve the level of care for these patients. In all cases, patient preferences should be considered when choosing a management strategy.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Sanda MG, Cadeddu JA, Kirkby E, et al. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options. J Urol. 2018. PMID: 29331546. doi:10.1016/j.juro.2018.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。